Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation

被引:10
作者
Brinkman, HJM [1 ]
Koster, P [1 ]
Mertens, K [1 ]
vanMourik, JA [1 ]
机构
[1] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT BLOOD COAGULAT,NL-1066 CX AMSTERDAM,NETHERLANDS
关键词
D O I
10.1042/bj3230735
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A localized and regulated cascade of proteolytic events is a prerequisite for normal haemostasis. The activation of factor X by activated factor IX (factor IXa) in the presence of activated factor VIII (factor VIIIa) is essential for the formation of a fibrin clot at sites of vascular injury. We observed sustained activation of factor X on the surface of vascular endothelial cells, whereas, in agreement with others, on synthetic negatively charged phospholipid vesicles and activated blood platelets factor X activation is transient and starts to decline a few minutes after the onset of the reaction. We examined the mechanism responsible for these differences in factor X activation. Procoagulant membrane and solution were analysed separately for the occurrence of factor VIII and its activation fragments. On negatively charged phospholipid vesicles, on dissociation of factor VIIIa, the 67 kDa light-chain fragment remains associated with the lipid membrane. As a result, factor VIII-binding sites remain occupied, and dampening of factor X activation occurs. In contrast, on monolayers of endothelial cells, no residual factor VIIIa fragments associated with the cell membrane were observed. During endothelial-cell-mediated activation of factor X, accumulation of factor VIIIa fragments was observed in the solution phase only. This finding suggests that, on endothelial cells, factor VIII-binding sites remain accessible for further factor VIII binding, guaranteeing sustained activation of factor X. These data demonstrate that the nature of the procoagulant membrane contributes to the regulation of the cofactor activity of factor VIII and thereby affects the progress of factor X activation.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 43 条
[21]  
LAMPHEAR BJ, 1992, BLOOD, V80, P3120
[22]   INHIBITION OF HUMAN COAGULATION FACTOR-VIII BY MONOCLONAL-ANTIBODIES - MAPPING OF FUNCTIONAL EPITOPES WITH THE USE OF RECOMBINANT FACTOR-VIII FRAGMENTS [J].
LEYTE, A ;
MERTENS, K ;
DISTEL, B ;
EVERS, RF ;
DEKEYZERNELLEN, MJM ;
GROENENVANDOOREN, MMCL ;
DEBRUIN, J ;
PANNEKOEK, H ;
VANMOURIK, JA ;
VERBEET, MP .
BIOCHEMICAL JOURNAL, 1989, 263 (01) :187-194
[23]  
LOLLAR P, 1990, J BIOL CHEM, V265, P1688
[24]   ACTIVATION OF PORCINE FACTOR-VIII-C BY THROMBIN AND FACTOR XA [J].
LOLLAR, P ;
KNUTSON, GJ ;
FASS, DN .
BIOCHEMISTRY, 1985, 24 (27) :8056-8064
[25]   SUBUNIT STRUCTURE OF THROMBIN-ACTIVATED PORCINE FACTOR-VIII [J].
LOLLAR, P ;
PARKER, CG .
BIOCHEMISTRY, 1989, 28 (02) :666-674
[26]  
LOLLAR P, 1991, J BIOL CHEM, V266, P12481
[27]  
LOLLAR P, 1992, J BIOL CHEM, V267, P23652
[28]  
MANN KG, 1992, SEMIN HEMATOL, V29, P213
[29]  
MERTENS K, 1982, THROMB HAEMOSTASIS, V47, P96
[30]   THE CONTRIBUTION OF CA-2+ AND PHOSPHOLIPIDS TO THE ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-X BY ACTIVATED FACTOR-IX [J].
MERTENS, K ;
BERTINA, RM .
BIOCHEMICAL JOURNAL, 1984, 223 (03) :607-615